Literature DB >> 20420515

Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases.

Becky A Miller1, Alice Gray, Thomas W Leblanc, Daniel J Sexton, Andrew R Martin, Thomas G Slama.   

Abstract

We describe 3 cases of daptomycin-induced pulmonary toxic effects that are consistent with drug-induced acute eosinophilic pneumonia. Patients presented similarly with dyspnea, cough, hypoxia, and diffuse ground-glass opacities at chest computed tomography. Clinical suspicion for this adverse drug event and cessation of daptomycin until definitive diagnosis can be made is crucial.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20420515     DOI： 10.1086/652656

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  19 in total

Review 1.  Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.

Authors:  Peter W Kim; Alfred F Sorbello; Ronald T Wassel; Tracy M Pham; Joseph M Tonning; Sumathi Nambiar
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

2.  Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention.

Authors:  Luke F Chen; Cody Chastain; Deverick J Anderson
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

Review 3.  Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.

Authors:  Ana Maria Rivera; Helen W Boucher
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

4.  A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

Authors:  C Rether; A Conen; M Grossenbacher; W C Albrich
Journal:  Infection       Date:  2011-06-30       Impact factor: 3.553

5.  Imipenem/cilastatin-induced acute eosinophilic pneumonia.

Authors:  Kap Sum Foong; Ashley Lee; Marijeta Pekez; Wei Bin
Journal:  BMJ Case Rep       Date:  2016-03-04

Review 6.  Antibiotics and bioactive natural products in treatment of methicillin resistant Staphylococcus aureus: A brief review.

Authors:  Arunava Kali
Journal:  Pharmacogn Rev       Date:  2015 Jan-Jun

7.  Chronic eosinophilic pneumonia due to radiographic contrast administration: an orphan disease?

Authors:  Wolfgang Hohenforst-Schmidt; Andreas Riedel; Paul Zarogoulidis; Christian Franke; Andreas Gschwendtner; Haidong Huang; Nikolaos Machairiotis; Vasiliki Dramba; Konstantinos Zarogoulidis; Johnannes Brachmann
Journal:  Drug Des Devel Ther       Date:  2012-12-10       Impact factor: 4.162

8.  Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients.

Authors:  Chung-Chih Lai; Wang-Huei Sheng; Jann-Tay Wang; Aristine Cheng; Yu-Chung Chuang; Yee-Chun Chen; Shan-Chwen Chang
Journal:  BMC Infect Dis       Date:  2013-02-04       Impact factor: 3.090

Review 9.  Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.

Authors:  Olatz Urbina; Olivia Ferrández; Mercè Espona; Esther Salas; Irene Ferrández; Santiago Grau
Journal:  Drug Des Devel Ther       Date:  2013-04-03       Impact factor: 4.162

Review 10.  Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections.

Authors:  Armando Gonzalez-Ruiz; R Andrew Seaton; Kamal Hamed
Journal:  Infect Drug Resist       Date:  2016-04-15       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.